Company intelligence / Profile preview
Encoded Therapeutics
South San Francisco, California, United Statesencoded.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Lead program ETX101 for Dravet syndrome is in clinical trials. ETX201 for Angelman syndrome is in development stage. Programs for chronic pain and Alzheimer's disease are in preclinical development.
- Therapeutic areas
- Neurology
- Modalities
- Gene therapyAAV vectorsVectorized miRNA
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
Prevail Therapeutics (Eli Lilly and Company)
Beyond the preview
Go deeper on Encoded Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Encoded Therapeutics.